Thermo Fisher raises over half of Patheon consideration in four tranches

Thermo Fisher Scientific 230x150
By Nigel Owen
20 Jul 2017

Thermo Fisher Scientific announced in May that it was to acquire Patheon for $7.2bn, including $2bn of net debt. Thermo Fisher expected to finance the deal with $5.2bn of debt and $2bn of equity. On Tuesday it put a big dent in the debt figure with a €2.6bn four tranche corporate bond offer.

According to Bloomberg data, Thermo Fisher has paid $29.2bn for various acquisitions in the past five years. In this period, the shares of Thermo Fisher have tripled to over $180 at Monday’s close.

Monday’s announcement about the call said Thermo Fisher was planning a multi-tranche euro transaction including ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.